Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Memantine and donepezil: a fixed drug combination for the treatment of moderate to severe Alzheimer's dementia.

Owen RT.

Drugs Today (Barc). 2016 Apr;52(4):239-48. doi: 10.1358/dot.2016.52.4.2479357. Review.

PMID:
27252988
2.

Suvorexant: efficacy and safety profile of a dual orexin receptor antagonist in treating insomnia.

Owen RT.

Drugs Today (Barc). 2016 Jan;52(1):29-40. doi: 10.1358/dot.2016.52.1.2439940. Review.

PMID:
26937493
3.

Folate augmentation of antidepressant response.

Owen RT.

Drugs Today (Barc). 2013 Dec;49(12):791-8. doi: 10.1358/dot.2013.49.12.2086138. Review.

PMID:
24524097
4.

Bupivacaine liposome injectable suspension: a new approach to postsurgical pain.

Owen RT.

Drugs Today (Barc). 2013 Aug;49(8):475-82. doi: 10.1358/dot.2013.49.8.2006992.

PMID:
23977664
5.

Inhaled loxapine: a new treatment for agitation in schizophrenia or bipolar disorder.

Owen RT.

Drugs Today (Barc). 2013 Mar;49(3):195-201. doi: 10.1358/dot.2013.49.3.1937429.

PMID:
23527323
6.

Perampanel: a novel antiepileptic for the adjunctive treatment of refractory partial onset seizures.

Owen RT.

Drugs Today (Barc). 2013 Jan;49(1):23-31. doi: 10.1358/dot.2013.49.1.1906424. Review.

PMID:
23362493
7.

The use of clobazam as an adjunctive treatment for Lennox-Gastaut syndrome.

Owen RT.

Drugs Today (Barc). 2012 Nov;48(11):697-703. doi: 10.1358/dot.2012.48.11.1879453. Review.

PMID:
23170305
8.

Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole.

Owen RT.

Drugs Today (Barc). 2012 Jul;48(7):469-78. doi: 10.1358/dot.2012.48.7.1832873. Review.

PMID:
22844658
9.

Lurasidone: a new treatment option for schizophrenia.

Owen RT.

Drugs Today (Barc). 2011 Nov;47(11):807-16. doi: 10.1358/dot.2011.47.11.1708832. Review.

PMID:
22146224
10.

Vilazodone: a new treatment option for major depressive disorder.

Owen RT.

Drugs Today (Barc). 2011 Jul;47(7):531-7. doi: 10.1358/dot.2011.47.7.1622076.

PMID:
22013560
11.

Eszopiclone: an update on its use in insomnia.

Owen RT.

Drugs Today (Barc). 2011 Apr;47(4):263-75. doi: 10.1358/dot.2011.47.4.1590792. Review.

PMID:
21573250
12.

Ezogabine: a novel antiepileptic as adjunctive therapy for partial onset seizures.

Owen RT.

Drugs Today (Barc). 2010 Nov;46(11):815-22. doi: 10.1358/dot.2010.46.11.1556435. Review.

PMID:
21225020
13.

Paliperidone palmitate injection: Its efficacy, safety and tolerability in schizophrenia.

Owen RT.

Drugs Today (Barc). 2010 Jul;46(7):463-71. doi: 10.1358/dot.2010.46.7.1514647. Review.

PMID:
20683501
14.

Olanzapine: a review of rapid and long-acting parenteral formulations.

Owen RT.

Drugs Today (Barc). 2010 Mar;46(3):173-81. doi: 10.1358/dot.2010.46.3.1476499. Review.

PMID:
20467591
15.

Eslicarbazepine acetate: A novel agent for the adjunctive treatment of epilepsy.

Owen RT.

Drugs Today (Barc). 2010 Jan;46(1):23-31. doi: 10.1358/dot.2010.46.1.1437709. Review.

PMID:
20200693
16.

Dapoxetine: a novel treatment for premature ejaculation.

Owen RT.

Drugs Today (Barc). 2009 Sep;45(9):669-78. doi: 1396674/dot.2009.45.9.1388694.

PMID:
19956808
17.

Agomelatine: a novel pharmacological approach to treating depression.

Owen RT.

Drugs Today (Barc). 2009 Aug;45(8):599-608. doi: 1396673/dot.2009.45.8.1396673. Review.

PMID:
19927226
18.

Novel zolpidem formulations.

Owen RT.

Drugs Today (Barc). 2009 May;45(5):395-400. doi: 10.1358/dot.2009.45.5.1370457. Review.

PMID:
19584967
19.

Selective histamine H(1) antagonism: a novel approach to insomnia using low-dose doxepin.

Owen RT.

Drugs Today (Barc). 2009 Apr;45(4):261-7. doi: 10.1358/dot.2009.45.4.1358835.

PMID:
19499091
20.

Controlled-release fluvoxamine in obsessive-compulsive disorder and social phobia.

Owen RT.

Drugs Today (Barc). 2008 Dec;44(12):887-93. doi: 10.1358/dot.2008.44.12.1299291. Review.

PMID:
19198698
21.

Milnacipran hydrochloride: its efficacy, safety and tolerability profile in fibromyalgia syndrome.

Owen RT.

Drugs Today (Barc). 2008 Sep;44(9):653-60. doi: 10.1358/dot.2008.44.9.1256003. Review.

PMID:
19137120
22.

Lubiprostone--a novel treatment for irritable bowel syndrome with constipation.

Owen RT.

Drugs Today (Barc). 2008 Sep;44(9):645-52. doi: 10.1358/dot.2008.44.9.1269852. Review.

PMID:
19137119
23.

Sodium oxybate: efficacy, safety and tolerability in the treatment of narcolepsy with or without cataplexy.

Owen RT.

Drugs Today (Barc). 2008 Mar;44(3):197-204. doi: 10.1358/dot.2008.44.3.1162240. Review.

PMID:
18536781
24.

Pregabalin: its efficacy, safety and tolerability profile in fibromyalgia syndrome.

Owen RT.

Drugs Today (Barc). 2007 Dec;43(12):857-63. doi: 10.1358/dot.2007.43.12.1140689. Review.

PMID:
18174971
25.

Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety.

Owen RT.

Drugs Today (Barc). 2007 Sep;43(9):601-10. Review.

PMID:
17940637
26.
27.

Extended-release zolpidem: efficacy and tolerability profile.

Owen RT.

Drugs Today (Barc). 2006 Nov;42(11):721-7. Review.

PMID:
17171191
28.

Extended-release carbamazepine for acute bipolar mania: a review.

Owen RT.

Drugs Today (Barc). 2006 May;42(5):283-9. Review.

PMID:
16801991
29.

Ramelteon: profile of a new sleep-promoting medication.

Owen RT.

Drugs Today (Barc). 2006 Apr;42(4):255-63. Review.

PMID:
16703122
30.

Olanzapine/fluoxetine combination for bipolar depression and other mood disorders: a review.

Owen RT.

Drugs Today (Barc). 2006 Mar;42(3):185-92. Review.

PMID:
16628260
31.

Histamine liberation with atracurium.

Owen RT.

Br J Anaesth. 1986 Nov;58(11):1342. No abstract available.

32.

The risk of pharmacological dependence with buspirone.

Tyrer P, Murphy S, Owen RT.

Br J Clin Pract Suppl. 1985 May;38:91-4. No abstract available.

PMID:
2862909
33.

Resistance to competitive neuromuscular blocking agents in burn patients: a review.

Owen RT.

Methods Find Exp Clin Pharmacol. 1985 Apr;7(4):203-7.

PMID:
4021651
34.

A clinical assessment of zuclopenthixol dihydrochloride (Clopixol tablets) in the treatment of psychotic illness.

Mann BS, Moslehuddin KS, Owen RT, Clayton AR, Rohatgi KK, Sud P, Vaddadi KS.

Pharmatherapeutica. 1985;4(6):387-92.

PMID:
2867559
35.

Withdrawal symptoms after six weeks' treatment with diazepam.

Murphy SM, Owen RT, Tyrer PJ.

Lancet. 1984 Dec 15;2(8416):1389. No abstract available.

PMID:
6150380
36.

The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale.

Tyrer P, Owen RT, Cicchetti DV.

J Neurol Neurosurg Psychiatry. 1984 Sep;47(9):970-5.

37.

Benzodiazepine dependence. A review of the evidence.

Owen RT, Tyrer P.

Drugs. 1983 Apr;25(4):385-98. Review.

PMID:
6133736
38.

Allopurinol and diuretic-induced hyperuricaemia.

Williams EB, Owen RT.

Lancet. 1980 Dec 20-27;2(8208-8209):1381. No abstract available.

PMID:
6109206
39.

Adjuvant induced polyarthritis - an overview.

Owen RT.

Methods Find Exp Clin Pharmacol. 1980 Aug;2(4):199-204. Review. No abstract available.

PMID:
7040861
40.

Intrastriatal kainic acid- a possible model for antidyskinetic/antichoreic agents?

Owen RT.

Methods Find Exp Clin Pharmacol. 1980 Apr;2(3):133-7.

PMID:
7339335
41.

Neuropharmacological supersensitivity-clinical and experimental correlates and methodological considerations.

Owen RT.

Methods Find Exp Clin Pharmacol. 1980 Apr;2(2):89-95. Review.

PMID:
6121962
42.

A critique of widely used neuropharmacological tests.

Owen RT.

Methods Find Exp Clin Pharmacol. 1979 Dec;1(5):269-75. No abstract available.

PMID:
575957
43.

Changes in dopamine-dependent motor behaviour caused by propranolol and its isomers.

Costall B, Naylor RJ, Nohria V, Owen RT.

J Pharm Pharmacol. 1978 Oct;30(10):657-60. No abstract available.

PMID:
30826
46.
47.

Investigations into the nature of the peri-oral movements induced by 2-(N-N-dipropyl) amino-5,6-dihydroxytetralin.

Costall B, Naylor RJ, Owen RT.

Eur J Pharmacol. 1977 Oct 15;45(4):357-67. No abstract available.

PMID:
562762
48.

Prostaglandin synthetase inhibitors and leucocytic emigration.

Blackham A, Owen RT.

J Pharm Pharmacol. 1975 Mar;27(3):201-3. No abstract available.

PMID:
238006

Supplemental Content

Support Center